Clinical Trial Methods for Assessing a Tobacco Product
Description: 

This is a multi-center trial involving University of Minnesota, Ohio State University and Roswell Park Cancer Center. Subjects who are eligible will enter a Camel Snus sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a 2 week baseline assessment phase and will then be randomized in the clinical trial phase to one of the five experimental conditions for 12 weeks.

Study Number: 

I 222712

Phase: 
Methodological Study
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01867242

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.